The Pharmaceuticals and Medical Devices Agency (PMDA) has added a new project team titled “Project team for Consideration of Guiding Principles for AI Utilization.” This team is part of the agency’s “Projects Across Multi‑Offices” program and will focus on developing guiding principles for the use of artificial intelligence in pharmaceutical and medical device contexts.
Cập nhật pháp chế24 thg 8, 2026•1 phút đọc
PMDA Adds Project Team for AI Utilization Guiding Principles
The Pharmaceuticals and Medical Devices Agency (PMDA) announced a new project team to develop guiding principles for AI utilization, listed under its “Projects Across Multi‑Offices” initiative.
Tổng hợp bởi đội ngũ PharmaCountry · Nguồn: Pharmaceuticals and Medical Devices Agency
Đánh giá
(0)
(0)
(0)
(0)
(0)
Bài viết khác
Xem tất cả bài viếtNghiên cứu & Báo cáo
Global Finished Dosage Manufacturing Landscape 2026
5 thg 10, 2026
Cập nhật pháp chếKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
28 thg 9, 2026
Phân tíchPharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
28 thg 9, 2026
Để lại đánh giá